A new super PAC with ties to a powerful New Jersey Democrat will begin airing a new TV ad today attacking Republican U.S. Senate candidate Hugin for earning millions by gouging cancer patients with an expensive-life saving drug.
The group, Leadership Alliance New Jersey, will air the ad on North Jersey cable systems, backed up by a “substantial six-figure buy.”
Leadership Alliance New Jersey is being run by Julie Roginsky, a powerhouse political strategist and consultant wrote the campaign plan that got Phil Murphy the Democratic gubernatorial nomination in 2017.
“Big Pharma Bob Hugin is spending the $100 million he earned gouging desperate cancer patients to buy himself a senate seat, so that he can go to Washington and further Donald Trump’s radical agenda,” said Roginsky. “At a time when cancer patients were forced to spend $700 dollars on a pill that cost Hugin less than one dollar to produce, Hugin hired DC lobbyists to fight against those who wanted to make this life-saving medication more affordable. Just imagine the damage he would do to New Jerseyans as a United States senator.”
Leadership Alliance | Title: “Get Rich” | TV :30 s | August 2018
Video:
Image: Bob Hugin.
Image: Book/Story graphic treatment.
ALT: Hard Copy News story graphic treatment.(Image Relay: Visuals of Hugin’s lavish lifestyle, including yacht, multiple homes and ski lodge.)CG: Bob Hugin, Chairman & CEO of CelgeneImage: Bottle of Revlimid.
CG: List Price: $700 dollars per pill, $20,000 per month.Image: FDA Names drugmakers potentially acting to delay cheaper, generics.
Image: “Hugin earned himself $100 million in just three years…”
CG: One Hundred Million DollarsImage: Republican Hugin spending millions to compete in New Jersey
CG: Bob Hugin spends $15.5 million on senate campaign.
CG: It’s up to you how this story ends.
Paid for by Leadership Alliance,leadershipalliancenj.com, not authorized by any candidate or candidate’s committee. Leadership Alliance is responsible for the content of this advertising.
Audio:
How did Bob Hugin build a lavish lifestyle off the backs of cancer patients?Step one: Take control of a giant pharmaceutical company.Step two: Charge $700 per pill for a critical cancer drug that only takes 65 cents to make.
[Drugs.com, Revlimid Prices][Twitter, “Today’s Drug Prices”, Meg Tirrell] [Bloomberg, The Loopholes Drug Companies Use to Keep Prices High, 12.20.17]Step three: Pay DC lobbyists millions to stop cheaper, life-saving versions of the cancer drug[Kaiser Health News, Drugmakers Dramatically Boosted Lobbying Spending In Trump’s First Quarter
,4.21.17][Bloomberg, A Drug Program That Keeps Patients Safe (And Profits, Too), 7.26.17]Step four: Pocket more than one hundred million dollars
[NJ, Is Menendez’s Republican challenger even more ethically challenged?, 3.418]His next step? Use that money from cancer patients to buy a Senate Seat?
VO: Leadership Alliance is responsible for the content of this advertising.
Back-up:
On June 16, 2010, Bob Hugin became CEO of Celgene. Source: http://ir.celgene.com/releasedetail.cfm?releaseid= 799385
As of 7/9/18, 100 capsules of Revlimid cost $69,547.81. Source: [Drugs.com, Revlimid Prices][Twitter, “Today’s Drug Prices”, Meg Tirrell]
On 12/20/17, Bloomberg reported that “a year’s worth of 10-milligram Revlimid doses costs about $240 to produce.” Source: https://www.bloomberg.com/news/features/2017-12-20/the- loopholes-drug-companies-use- to-keep-prices-highIn 2017-2018, Celgene spent $4.64 million on lobbying. Sources:https://www.opensecrets.org/ lobby/clientsum.php?id= D000032432&year=2018Celgene’s lobbyists work on the company’s behalf to delay cheaper generic drugs from coming to market.
Sources: [Bloomberg, A Drug Program That Keeps Patients Safe (And Profits, Too), 7.26.17]
[Reuters, FDA names drugmakers potentially acting to delay cheap generics
5.17.18]; https://www.nj.com/opinion/index.ssf/2018/02/did_hugins_ company_celgene_endanger_ cancer_patient.htmlHugin has earned $100 million in salary, benefits, stock, and stock options from Celgene. ($48 million in salary and benefits in 2017, $22.5 million in 2016, $22.47 million in salary in 2015; $24.24 million in salary in 2014.) https://efdsearch.senate.gov/ search/print/paper/d321b4c6- dfd6-486b-a6a2-3377ee013b93/;
https://www.fiercepharma.com/pharma/celgene-chief-hugin- nabs-22m-for-his-ceo-swan-song
https://www.fiercepharma.com/special-report/top-20-highest- paid-biopharma-ceos
https://www.biospace.com/article/5-highest-paid- biopharma-ceos-of-2016-/ Hugin has put $15.5 million of his own money into his 2018 campaign for U.S. Senate. [WTOP, Republican Hugin spending millions to compete in New Jersey, 7.21.18]
###
One thought on “New super PAC attacks Hugin on price of cancer drugs”